We are live on !
Find out more
Engaged Capital Portfolio holdings
AUM
$327M
Turnover
10%
1-Year Est. Return
22.96%
This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+22.96%
3 Year Est. Return
+26.15%
5 Year Est. Return
+72.38%
10 Year Est. Return
+552.21%
AUM
$307M
AUM Growth
+$32.1M
(+12%)
Cap. Flow
+$19M
Cap. Flow % of AUM
Cap. Flow %
6.19%
Top 10 Holdings %
Top 10 Hldgs %
96.9%
Holding
16
New
2
Increased
5
Reduced
3
Closed
2
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$25.6M |
| 2 |
PRXL
Parexel International Corp
PRXL
|
+$4.21M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$2.5M |
| 4 |
TIVO
Tivo Inc
TIVO
|
+$1.52M |
| 5 |
Medifast
MED
|
+$1.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comscore
SCOR
|
+$7.11M |
| 2 |
LBY
Libbey, Inc.
LBY
|
+$4.28M |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$3.45M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$2.52M |
| 5 |
TriMas Corp
TRS
|
+$980K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.38% |
| 2 | Consumer Discretionary | 20.24% |
| 3 | Industrials | 17.2% |
| 4 | Consumer Staples | 14.97% |
| 5 | Healthcare | 2.09% |
Similar funds
DS
RL
CIM
Engaged Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Engaged Capital held 16 positions worth $307M, up 12% from $275M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Engaged Capital deployed $19M of net new capital in Q4 2016, opening 2 new positions and adding to 5 existing holdings. Its largest new stake was Upbound Group: 2,302,376 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was BioDelivery Sciences International, Inc., an estimated $3.45M trimmed.
- Engaged Capital's largest Q4 2016 buy was Upbound Group: 2,302,376 shares worth $25.9M.
- Engaged Capital added most to Parexel International Corp in Q4 2016, an estimated $4.21M increase.
- Engaged Capital's biggest Q4 2016 reduction was BioDelivery Sciences International, Inc., cutting an estimated $3.45M.
- Engaged Capital fully exited Comscore in Q4 2016, selling an estimated $7.11M.
- Engaged Capital's ten largest holdings make up 97% of its $307M portfolio in Q4 2016.
- Engaged Capital opened 2 new positions and closed 2 in Q4 2016.
- Engaged Capital's portfolio value rose 12% quarter-over-quarter to $307M.
Based on Engaged Capital's 13F filing for Q4 2016, filed 14 Feb 2017.